VOR logo

VOR
Vor Biopharma Inc

2,122
Mkt Cap
$748.34M
Volume
14,903.00
52W High
$65.80
52W Low
$2.62
PE Ratio
-0.05
VOR Fundamentals
Price
$15.32
Prev Close
$15.32
Open
$15.27
50D MA
$14.77
Beta
1.07
Avg. Volume
1.05M
EPS (Annual)
-$70.50
P/B
-3.61
Rev/Employee
$0.00
$323.08
Loading...
Loading...
News
all
press releases
Vor Biopharma (NASDAQ:VOR) Director Sells $2,711,856.51 in Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 171,963 shares of the stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $15.77, for a total transaction of $2,711,856.51. Following the sale, the...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Vor Biopharma (NASDAQ:VOR) Director Sells $7,462,931.08 in Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 458,411 shares of the firm's stock in a transaction that occurred on Friday, April 17th. The shares were...
MarketBeat·2d ago
News Placeholder
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 171,963 Shares of Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 171,963 shares of the company's stock in a transaction dated Monday, April 20th. The stock was sold at an...
MarketBeat·2d ago
News Placeholder
Vor Biopharma (NASDAQ:VOR) Shares Down 4.4% - Here's What Happened
Vor Biopharma (NASDAQ:VOR) Shares Down 4.4% - Here's What Happened...
MarketBeat·3d ago
News Placeholder
Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 117% in Vor Biopharma (VOR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·3d ago
News Placeholder
Vor Biopharma (NASDAQ:VOR) Trading 9.7% Higher - What's Next?
Vor Biopharma (NASDAQ:VOR) Trading 9.7% Higher - What's Next...
MarketBeat·6d ago
News Placeholder
Vor Biopharma Q1 EPS Estimate Increased by HC Wainwright
Vor Biopharma Inc. (NASDAQ:VOR - Free Report) - HC Wainwright raised their Q1 2026 EPS estimates for Vor Biopharma in a report issued on Tuesday, April 14th. HC Wainwright analyst S. Ramakanth now...
MarketBeat·6d ago
News Placeholder
Ra Capital Management, L.P. Sells 53,644 Shares of Vor Biopharma (NASDAQ:VOR) Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 53,644 shares of Vor Biopharma stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $16.01, for a total value of $858,840.44. Following the sale, the director...
MarketBeat·7d ago
News Placeholder
Ra Capital Management, L.P. Sells 530,610 Shares of Vor Biopharma (NASDAQ:VOR) Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 530,610 shares of the firm's stock in a transaction dated Monday, April 13th. The stock was sold at an...
MarketBeat·8d ago
News Placeholder
Vor Biopharma (NASDAQ:VOR) Director Sells $858,840.44 in Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 53,644 shares of the business's stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $16.01, for a total transaction of $858,840.44. Following the completion of the...
MarketBeat·8d ago
<
1
2
...
>

Latest VOR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.